A Pilot Trial to Determine the Efficacy of VSL#3 for Reducing Colonization by VRE

Completed · Phase 2 · Has a placebo group

Conditions studied: Anti-biotic Resistance

In brief

The purpose of this study is to investigate the feasibility, safety and efficacy of oral probiotic, VSL#3 versus oral placebo for reducing colonization by VRE.

Key facts

Study ID

NCT00933556

Run by

University of Wisconsin, Madison

People needed

90

Starts

2008-10-01

Expected to finish

2012-03-01

Last updated by the study team

2015-10-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• subjects will be male or female
• 18 years of age or older
• may or may not be hospitalized
• able to take oral medications
• have been found to be colonized with VRE or at high risk of being colonized by VRE and are not taking antibiotics

You may not qualify if…

• people on antibiotics will not be eligible to participate

Where it is running

• University of wisconsin hospital — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.